VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement

VERAXA Biotech AG has strengthened its financial position to position to support the closing of its business combination with Voyager Acquisition Corp.